Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes (marketed as Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (marketed as Zepbound)
PubChem Compound Summary for CID 892, myo-Inositol
Advertisement Advertisement Trending on Pharmacy Times 1 Learning Curves Don't Come With a Package Insert 2 July 2026 in Pain Management: 10 Developments That Advanced and Challenged Patient Care 3 Five Solid Tumor Advances That Defined July 2026 4 Inside Phoebe Putneys Medication Management Clinic: How One Rural Health System Saved $1 Million and Cut Readmissions 5
The most well-known is tirzepatide (Mounjaro or Zepbound)
US$ 29.76
US$ 25.17
US$ 28.57
